BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 16949381)

  • 21. Prevention of iodinated contrast-induced nephropathy.
    Li JH; He NS
    Chin Med J (Engl); 2011 Dec; 124(23):4079-82. PubMed ID: 22340345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contrast-induced nephropathy.
    Pucelikova T; Dangas G; Mehran R
    Catheter Cardiovasc Interv; 2008 Jan; 71(1):62-72. PubMed ID: 17975790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of contrast-induced nephropathy with volume expansion.
    Weisbord SD; Palevsky PM
    Clin J Am Soc Nephrol; 2008 Jan; 3(1):273-80. PubMed ID: 17989201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence of contrast-induced nephropathy with volume supplementation--insights from a large cohort.
    Mueller-Lenke N; Buerkle G; Klima T; Breidthardt T; Buettner HJ; Mueller C
    Med Princ Pract; 2008; 17(5):409-14. PubMed ID: 18685283
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors and therapy strategies for contrast-induced nephropathy.
    Toprak O; Cirit M
    Ren Fail; 2006; 28(5):365-81. PubMed ID: 16825085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathophysiology of contrast-induced nephropathy.
    Tumlin J; Stacul F; Adam A; Becker CR; Davidson C; Lameire N; McCullough PA;
    Am J Cardiol; 2006 Sep; 98(6A):14K-20K. PubMed ID: 16949376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of N-acetylcysteine and hydration versus placebo and hydration in decreasing contrast-induced renal dysfunction in patients undergoing coronary angiography with or without concomitant percutaneous coronary intervention.
    Seyon RA; Jensen LA; Ferguson IA; Williams RG
    Heart Lung; 2007; 36(3):195-204. PubMed ID: 17509426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of contrast-induced nephropathy: a critical review.
    Van Praet JT; De Vriese AS
    Curr Opin Nephrol Hypertens; 2007 Jul; 16(4):336-47. PubMed ID: 17565276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Baseline renal function screening.
    Lameire N; Adam A; Becker CR; Davidson C; McCullough PA; Stacul F; Tumlin J;
    Am J Cardiol; 2006 Sep; 98(6A):21K-26K. PubMed ID: 16949377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What are radiologists doing to prevent contrast-induced nephropathy (CIN) compared with measures supported by current evidence? A survey of European radiologists on CIN associated with computed tomography.
    Fishman EK; Reddan D
    Acta Radiol; 2008 Apr; 49(3):310-20. PubMed ID: 18365820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk prediction of contrast-induced nephropathy.
    McCullough PA; Adam A; Becker CR; Davidson C; Lameire N; Stacul F; Tumlin J;
    Am J Cardiol; 2006 Sep; 98(6A):27K-36K. PubMed ID: 16949378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contrast-induced nephropathy: the wheel has turned 360 degrees.
    Thomsen HS; Morcos SK; Barrett BJ
    Acta Radiol; 2008 Jul; 49(6):646-57. PubMed ID: 18568557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contrast-induced nephropathy: epidemiology and prevention.
    Bagshaw SM; Culleton BF
    Minerva Cardioangiol; 2006 Feb; 54(1):109-29. PubMed ID: 16467746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prevention of contrast-induced nephropathy using cardiac catheterization combined with hydration, oral N-acetylcysteine, sodium bicarbonate and iso-osmolar contrast agents].
    Hoshino A; Enomoto S; Kawahito H; Kurata H; Nakahara Y; Nakamura T
    J Cardiol; 2007 Aug; 50(2):119-26. PubMed ID: 17802695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reducing the risks for contrast-induced nephropathy.
    Stacul F
    Cardiovasc Intervent Radiol; 2005; 28 Suppl 2():S12-8. PubMed ID: 16419278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of postoperative acute renal failure.
    Reddy VG
    J Postgrad Med; 2002; 48(1):64-70. PubMed ID: 12082335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contrast-Induced Nephropathy (CIN) Consensus Working Panel: executive summary.
    McCullough PA; Stacul F; Becker CR; Adam A; Lameire N; Tumlin JA; Davidson CJ;
    Rev Cardiovasc Med; 2006; 7(4):177-97. PubMed ID: 17224862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective renal arterial infusion of fenoldopam for the prevention of contrast-induced nephropathy.
    Ng MK; Tremmel J; Fitzgerald PJ; Fearon WF
    J Interv Cardiol; 2006 Feb; 19(1):75-9. PubMed ID: 16483344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Strategies to prevent contrast nephropathy.
    Oudemans-van Straaten HM
    Minerva Cardioangiol; 2005 Oct; 53(5):445-63. PubMed ID: 16179886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contrast-induced nephropathy.
    Ray S; Dutta A
    Indian Heart J; 2008; 60(2):133-8. PubMed ID: 19218722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.